SCHEMBL12495903

SCHEMBL12495903

CCCCc1c(-c2ccoc2)nc(N)nc1-c1ccsc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.44
▸ ADORA1 P30542 4/20 0.39
▸ DRD2 P14416 2/20 0.38
▸ HTR6 P50406 2/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ TLR7 Q9NYK1 3/20 0.35
▸ TLR8 Q9NR97 4/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ ADK P55263 1/20 0.32
▸ KDM4A O75164 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21313181 0.88 ADORA2A (0.54) ADORA2AADORA1DRD2HTR6HTR1A
SCHEMBL16223017 0.88 ADORA2A (0.47) ADORA2AADORA1DRD2HTR6TLR7
SCHEMBL21313222 0.84 ADORA2A (0.47) ADORA2AADORA1DRD2HTR6HTR1A
SCHEMBL21313192 0.82 ADORA2A (0.45) ADORA2AADORA1DRD2HTR6TLR7
SCHEMBL12495875 0.82 ADORA2A (0.58) ADORA2AADORA1DRD2HTR6HTR1A
SCHEMBL16223135 0.82 ADORA2A (0.58) ADORA2AADORA1DRD2HTR6TLR7
SCHEMBL21313191 0.81 ADORA2A (0.45) ADORA2AADORA1DRD2HTR6HTR1A
SCHEMBL16223064 0.81 ADORA2A (0.45) ADORA2AADORA1HPGDNPSR1DHFR
SCHEMBL21313268 0.80 ADORA2A (0.46) ADORA2AADORA1DRD2HTR6HTR1A
SCHEMBL16223083 0.80 ADORA2A (0.43) ADORA2AADORA1DRD2HTR6TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US claimed
EP-2680847-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) 2014-01-08 — — EP disclosed
WO-2012116666-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2012-09-07 — — WO disclosed
Send feedback